KI04 an Aminoglycosides-Derived Molecule Acts as an Inhibitor of Human Connexin46 Hemichannels Expressed in HeLa Cells

Vista sencilla de ítem
dc.contributor.authorChang, Cheng-Wei T.
dc.contributor.authorPoudyal, Naveena
dc.contributor.authorVerdugo, Daniel A.
dc.contributor.authorPeña, Francisca
dc.contributor.authorStehberg, Jimmy
dc.contributor.authorRetamal, Mauricio A.
dc.date.accessioned2023-10-17T23:21:25Z
dc.date.available2023-10-17T23:21:25Z
dc.date.issued2023-02
dc.descriptionIndexación: Scopuses
dc.description.abstractBackground: Connexins (Cxs) are proteins that help cells to communicate with the extracellular media and with the cytoplasm of neighboring cells. Despite their importance in several human physiological and pathological conditions, their pharmacology is very poor. In the last decade, some molecules derived from aminoglycosides have been developed as inhibitors of Cxs hemichannels. However, these studies have been performed in E. coli, which is a very simple model. Therefore, our main goal is to test whether these molecules have similar effects in mammalian cells. Methods: We transfected HeLa cells with the human Cx46tGFP and characterized the effect of a kanamycin-derived molecule (KI04) on Cx46 hemichannel activity by time-lapse recordings, changes in phosphorylation by Western blot, localization by epifluorescence, and possible binding sites by molecular dynamics (MD). Results: We observed that kanamycin and KI04 were the most potent inhibitors of Cx46 hemichannels among several aminoglycosides, presenting an IC50 close to 10 μM. The inhibitory effect was not associated with changes in Cx46 electrophoretic mobility or its intracellular localization. Interestingly, 5 mM DTT did not reverse KI04 inhibition, but the KI04 effect completely disappeared after washing out KI04 from the recording media. MD analysis revealed two putative binding sites of KI04 in the Cx46 hemichannel. Results: These results demonstrate that KI04 could be used as a Cx46 inhibitor and could help to develop future selective Cx46 inhibitors. © 2023 by the authors.es
dc.description.urihttps://www.mdpi.com/2218-273X/13/3/411
dc.identifier.citationBiomolecules Open Access Volume 13, Issue 3February 2023 Article number 411es
dc.identifier.doi10.3390/biom13030411
dc.identifier.issn2218-273X
dc.identifier.urihttps://repositorio.unab.cl/xmlui/handle/ria/53487
dc.language.isoenes
dc.publisherMDPIes
dc.rights.licenseAtribución 4.0 Internacional (CC BY 4.0)
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/deed.es
dc.subjectAminoglycosideses
dc.subjectCanceres
dc.subjectConnexinses
dc.subjectHemichannelses
dc.subjectInhibitorses
dc.subjectLenses
dc.titleKI04 an Aminoglycosides-Derived Molecule Acts as an Inhibitor of Human Connexin46 Hemichannels Expressed in HeLa Cellses
dc.typeArtículoes
Archivos
Bloque original
Mostrando 1 - 1 de 1
Miniatura
Nombre:
Chang_C_KI04_an_Aminoglycosides_Derived_Molecule_2023_Article.pdf
Tamaño:
2.02 MB
Formato:
Adobe Portable Document Format
Descripción:
TEXTO COMPLETO EN INGLES
Descargar
Bloque de licencias
Mostrando 1 - 1 de 1
No hay miniatura disponible
Nombre:
license.txt
Tamaño:
1.71 KB
Formato:
Item-specific license agreed upon to submission
Descripción:
Descargar
Colecciones
Fac.CV - Artículos de Revista